BeOne Medicines Ltd. American Depositary Shares (ONC) Financials
Key financial figures for BeOne Medicines Ltd. American Depositary Shares (Q2 2026).
BeOne Medicines AG reported revenue of $1.71 billion for Q2 FY2026, up 29.6% from the same period a year earlier. Net income was $237.0 million, or $26.65 per share. Operating margin came to 19.06%, against 6.68% a year earlier. Free cash flow for the period was $595.9 million. Across the last 5 reported quarters, quarterly revenue has risen from $1.32 billion in Q2 FY2025 to $1.71 billion in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for BeOne Medicines AG are on the SentiSense financials page.
- Revenue
- $1.7B
- Net Income
- $237M
- EPS
- $27.04
- Total Assets
- $9.2B
- Operating Cash Flow
- $664M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $1.7B | $237M | $26.65 | 19.06% | $596M |
| Q1 FY2026 | $1.5B | $227M | $25.35 | 16.51% | $161M |
| Q4 FY2025 | $1.5B | $67M | $6.76 | 12.35% | $131M |
| Q3 FY2025 | $1.4B | $125M | $13.52 | 11.55% | $354M |
| Q2 FY2025 | $1.3B | $94M | $0.84 | 6.68% | $200M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $5.3B | $287M | $32.11 | 8.37% | $942M |
| FY2024 | $3.8B | -$645M | -$6.12 | -14.91% | -$670M |
| FY2023 | $2.5B | -$882M | -$8.45 | -49.12% | -$1.8B |
Frequently asked questions
What was BeOne Medicines AG's revenue last quarter?
BeOne Medicines AG reported revenue of $1.71 billion for Q2 FY2026, up 29.6% from the same period a year earlier.
Is BeOne Medicines AG profitable?
Yes. BeOne Medicines AG reported net income of $237.0 million for Q2 FY2026, a net margin of 13.9% on revenue.
How has BeOne Medicines AG's margin trended?
Operating margin was 19.06% in Q2 FY2026, compared with 6.68% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did BeOne Medicines AG generate?
BeOne Medicines AG generated free cash flow of $595.9 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for BeOne Medicines Ltd. American Depositary Shares on SentiSense, with up to forty quarters and twenty fiscal years of history.